Frates James Minsider trades

In SEC Form 4 filings, Frates James M is listed as Chief Financial Officer of Amylyx Pharmaceuticals, Inc. (AMLX). In the last 90 days, Frates James M sold $349.8K of Amylyx Pharmaceuticals, Inc. (AMLX) on the open market and bought none.

Companies and roles

Company	Role	Transactions	Last filed
AMLXAmylyx Pharmaceuticals, Inc.	Chief Financial Officer	2	Sep 14

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-14

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
AMLXAmylyx Pharmaceuticals, Inc.	Sep 10	Sep 14	S	9,768	$32.27	Sale −$315,195	234,667	No	Form 4
AMLXAmylyx Pharmaceuticals, Inc.	Sep 10	Sep 14	S	1,042	$33.23	Sale −$34,626	233,625	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.